Latest News
Search News
Targeting healthy cells changes invasive behaviour of pancreatic cancer
25th January 2022
Researchers from Barts Cancer Institute at Queen Mary University of London, led by Dr Angus Cameron, have found a way to modulate the invasive behaviour of pancreatic cancer by targeting a non-cancerous cell type found within pancreatic tumours. The findings, published in Cell Reports, provide valuable insights into the biology of pancreatic cancer progression, and could help to drive improvements in cancer treatment.
Read more
Turning back the molecular clock: Tracing cell lineage
6th January 2022
Researchers from Barts Cancer Institute at Queen Mary University of London, the Moffitt Cancer Center and the University of Southern California, have developed a new method that measures subtle changes to the genetic code of cells (called DNA methylation) to study the dynamics of what happens to cells within our bodies over time. The new method, published in Nature Biotechnology, provides a way to measure the birth and death of human cells, making it possible to trace cell lineage and evolution.
Read more
Professor Nick Lemoine recognised in the New Year Honours List
5th January 2022
Congratulations to Professor Nick Lemoine, Director of Barts Cancer Institute at Queen Mary University of London, who has received a CBE for services to clinical research, particularly during COVID-19.
Read more
Barts Cancer Institute at ASH 2021
17th December 2021
In December each year, the American Society of Hematology (ASH) hosts its Annual Meeting and Exposition – the premier event in malignant and non-malignant haematology. The event represents an invaluable opportunity for researchers at Barts Cancer Institute, Queen Mary University of London to highlight their blood cancer research on an international stage.
Read more
Investigating new strategies to target lung cancer
6th December 2021
Recent research from Barts Cancer Institute (BCI) at Queen Mary University of London has identified a novel therapeutic strategy to target lung cancer tumours that lack the gene LIMD1. We spoke with Professor Tyson V Sharp from BCI’s Centre for Cancer Cell & Molecular Biology, who led the study with Dr Sarah Martin, to find out more about the research and the significance of the findings.
Read more
Barts Cancer Institute hosts its first Robotic Surgery Symposium
3rd December 2021
On 4th November 2021, Barts Cancer Institute at Queen Mary University of London, in partnership with Barts Health NHS Trust, hosted its first Robotic Surgery Symposium, focused on the use of robotic systems for minimally invasive (or laparoscopic) surgery.
Read more